Deep-Dive Due Diligence AI Generated Probe of Tenon Medical, Inc. Common Stock (TNON)

Welcome to ScanScor. What you're reading is not just a stock summary -- it's a real-time, AI-generated due diligence session crafted from live news, financial data, insider trading activity, SEC filings, and live market momentum.

These auto-generated reports apply OpenAI's GPT-based analysis engine, guided by tightly structured prompts and expert-level data ingestion. Every insight below was assembled to help you understand the forces behind today's market movers.

Disclaimer: This report is for informational purposes only. It does not constitute financial advice. Always do your own research before making any investment.


TNON_OUT_1 [2025-03-27 09:44:44 -0400] 2559 Bytes | 762 tokens | Cum: 762 tkns (9.53% of 8k)
==========================================================================

We're scouting for winners today. Its 9:44:41 AM on Thu Mar 27, 2025 -0400 and I'm looking at Tenon Medical (TNON) up to 3.05 from 2.42

Help me investigate to see if its got potential or just another dud. So, I pulled together a bunch of data for you to look over real fast.

Here's the first list of news for Tenon Medical:

C1 - Mar-25-25 08:10PM - Tenon Medical, Inc. Announces Pricing of $2.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules
C2 - Mar-25-25 08:10PM 12:45PM - Tenon Medical, Inc. Announces a Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules
C3 - Mar-24-25 04:05PM - Tenon Medical(R) Announces FDA Clearance of Catamaran(R) SI Joint Fusion System for New Indication to Augment Spinal Fusion
C4 - Mar-20-25 06:40PM - Tenon Medical, Inc. (TNON) Q4 2024 Earnings Call Transcript
C5 - Mar-20-25 06:40PM 04:05PM - Tenon Medical Reports Fourth Quarter and Full Year 2024 Financial Results
C6 - Mar-11-25 03:40PM - Tenon Medical, Inc. Announces a Warrant Inducement Transaction for $3.0 Million in Gross Proceeds
C7 - Mar-10-25 04:05PM - Tenon Medical(R) Receives Approval for Notice of Allowance from the European Patent Office
C8 - Mar-07-25 08:00AM - Tenon Medical, Inc. Announces Timing of Fourth Quarter and Full Year 2024 Financial Results

Prior AI Reports for TNON:

1. 2025-03-27 – Score: – – Target: – – Highs: – / – / –

2. 2025-03-25 – Score: 30 – Target: 2.7500 – Highs: 5.8500 / 3.2000 / –
tenon-medical-struggles-amid-declining-sales-and-share-price
3. 2025-03-24 – Score: 45 – Target: 1.5000 – Highs: 1.0000 / 5.8500 / 3.20
tenon-medical-a-bumpy-ride-with-potential-upside

(Note: Highs = Same day / 2nd day / 3rd day)

ONLY 3 RULES for AI:
==============
1) I am a document retrieval system. You are the analyst-investigator.
2) You can request items from my lists to get more info on Tenon Medical (TNON)
3) AFTER requesting and reading News and SEC filings you'll write a summary, set a score, high price target and headline.
Now, your response should be only 2 or 3 chars. You can say ex., C1, C2, etc., or NEX
The NEX command delivers the NEXt list of News/SEC/Metrics
There are several more lists that use our unified document retrieval system in subsequent prompts.
Your predictons will be compared to reality to rate your accuracy. Try to predict accurately. GOOD LUCK!
Please request a document, read, summarize and score. Say something like "C1".

TNON_IN_2 [2025-03-27 09:44:44 -0400] 2 Bytes | 2 tokens | Cum: 764 tkns (9.55% of 8k)
==========================================================================

C3

TNON_OUT_3 [2025-03-27 09:44:48 -0400] 553 Bytes | 169 tokens | Cum: 933 tkns (11.66% of 8k)
==========================================================================

Showing C3 (chunk 1 of 1): C3:
**Tenon Medical(R) Announces FDA Clearance of Catamaran(R) SI Joint Fusion System for New Indication to Augment Spinal Fusion**
Date: Mar-24-25 04:05PM
Source: (ACCESSWIRE)
URL: https://www.accesswire.com/viewarticle.aspx?id=1004697

Error fetching article: 403 Client Error: Forbidden for url: https://www.accesswire.com/viewarticle.aspx?id=1004697

--> You can ask for 1) More of this item with: MOR, 2) the NEXt section with: NEX, or 3) a different item by it's handle (ex. C3, S2) (only 3 chars don't summarize yet)

TNON_IN_4 [2025-03-27 09:44:48 -0400] 290 Bytes | 60 tokens | Cum: 993 tkns (12.41% of 8k)
==========================================================================

Tenon Medical has announced that the FDA has cleared their Catamaran SI Joint Fusion System for a new indication to augment spinal fusion. The announcement was made on March 24th, 2025. Unfortunately, no more details about the clearance can be provided due to an error fetching the article.

TNON_OUT_5 [2025-03-27 09:44:50 -0400] 969 Bytes | 298 tokens | Cum: 1291 tkns (16.14% of 8k)
==========================================================================

We present this news so you can catch the big movers from recently breaking news.
Here's a list of news articles you can literally read just by asking.
Usually the first item is the most important.

A1 - 2025-03-26T17:05:38Z - 12 Health Care Stocks Moving In Wednesday's Intraday Session - Acrivon Therapeutics (NASDAQ:ACRV), A...
A2 - 2025-03-26T15:45:20Z - Why Tenon Medical (TNON) Shares Are Getting Hammered - Tenon Medical (NASDAQ:TNON)...
A3 - 2025-03-26T13:18:00Z - Pre-market Movers: OSRH, SURG, BLNE, HUMA, TNON....
A4 - 2025-03-26T12:11:54Z - 12 Health Care Stocks Moving In Wednesday's Pre-Market Session - AquaBounty Techs (NASDAQ:AQB), Acla...
A5 - 2025-03-26T00:22:07Z - Tenon Medical, Inc. Announces Pricing of $2.5 Million Registered Direct Offering and Concurrent Priv...

Request an article by its reference number. (Ex., "A1" gets the first item)
You may also say NEX to go to the next listing.
Response to this prompt limited to 3 chars.

TNON_IN_6 [2025-03-27 09:44:50 -0400] 2 Bytes | 2 tokens | Cum: 1293 tkns (16.16% of 8k)
==========================================================================

A1

TNON_OUT_7 [2025-03-27 09:44:51 -0400] 1098 Bytes | 344 tokens | Cum: 1637 tkns (20.46% of 8k)
==========================================================================

Showing A1 (chunk 1 of 3): A1:
**12 Health Care Stocks Moving In Wednesday's Intraday Session - Acrivon Therapeutics (NASDAQ:ACRV), Aclarion (NASDAQ:ACON)**Date: 2025-03-26Source: {'uri': 'benzinga.com', 'dataType': 'news', 'title': 'Benzinga'}URL: https://www.benzinga.com/insights/movers/25/03/44498940/12-health-care-stocks-moving-in-wednesdays-intraday-sessionGainers Petros Pharma PTPI shares rose 246.0% to $0.2 during Wednesday's regular session. The market value of their outstanding shares is at $5.0 million. OSR Holdings OSRH shares increased by 112.49% to $3.4. The market value of their outstanding shares is at $65.5 million. Ocean Biomedical OCEA stock increased by 92.07% to $0.11. The company's market cap stands at $15.3 million. AquaBounty Techs AQB stock increased by 46.09% to $0.99. The market value of their outstanding shares is at $3.8 million. Aspira Womens Health AWH stock increased by 21.36% to $0.

--> You can ask for 1) More of this item with: MOR, 2) the NEXt section with: NEX, or 3) a different item by it's handle (ex. C3, S2) (only 3 chars don't summarize yet)

TNON_IN_8 [2025-03-27 09:44:51 -0400] 3 Bytes | 2 tokens | Cum: 1639 tkns (20.49% of 8k)
==========================================================================

NEX

TNON_OUT_9 [2025-03-27 09:44:53 -0400] 949 Bytes | 303 tokens | Cum: 1942 tkns (24.27% of 8k)
==========================================================================

This is our final list of news.
News AI can literally read just by asking.
Don't miss the breaking news!

B1 - 2024-03-13T12:24:11Z - Why SurgePays Shares Are Trading Lower By Around 15%; Here Are 20 Stocks Moving Premarket
B2 - 2023-11-13T18:08:54Z - Why Edible Garden Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Monday's Mid-Day Session
B3 - 2023-11-07T13:28:51Z - Why Alteryx Shares Are Trading Higher By Around 16%; Here Are 20 Stocks Moving Premarket
B4 - 2023-11-03T17:26:11Z - Why Fortinet Shares Are Trading Lower By Around 17%? Here Are Other Stocks Moving In Friday's Mid-Day Session
B5 - 2023-11-03T16:12:08Z - Dow Surges Over 200 Points; ISM Services PMI Falls In October
B6 - 2023-11-03T14:02:16Z - Nasdaq Gains 1%; US Adds 150,000 Jobs In October

Request an article by its reference number. (Ex., "B1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.

TNON_IN_10 [2025-03-27 09:44:53 -0400] 2 Bytes | 2 tokens | Cum: 1944 tkns (24.30% of 8k)
==========================================================================

B3

TNON_OUT_11 [2025-03-27 09:44:59 -0400] 1098 Bytes | 319 tokens | Cum: 2263 tkns (28.29% of 8k)
==========================================================================

Showing B3 (chunk 1 of 2): B3:
**Why Alteryx Shares Are Trading Higher By Around 16%; Here Are 20 Stocks Moving Premarket**Date: Unknown DateSource: Unknown SourceURL: https://www.benzinga.com/news/23/11/35641532/why-alteryx-shares-are-trading-higher-by-around-16-here-are-20-stocks-moving-premarketGainers
Senti Biosciences, Inc. (NASDAQ: SNTI) shares surged 120.8% to $0.6450 in pre-market trading after the company reported a new strategic collaboration with Celest Therapeutics for the clinical development of SENTI-301A in China.
Tharimmune, Inc. (NASDAQ: THAR) shares rose 76.8% to $0.2790 in pre-market trading as the company disclosed the execution of an exclusive worldwide licensing agreement with Avior Inc. d/b/a Avior Bio, LLC to develop, market and commercialize a clinical-stage asset, AV104.
TransMedics Group, Inc. (NASDAQ: TMDX) shares rose 39.7% to $56.16 in pre-market trading after the company reported b

--> You can ask for 1) More of this item with: MOR, 2) the NEXt section with: NEX, or 3) a different item by it's handle (ex. C3, S2) (only 3 chars don't summarize yet)

TNON_IN_12 [2025-03-27 09:44:59 -0400] 627 Bytes | 142 tokens | Cum: 2405 tkns (30.06% of 8k)
==========================================================================

This report highlights the significant premarket movements of several stocks. Alteryx shares are trading higher by around 16% for reasons not specified in the excerpt. Senti Biosciences shares surged 120.8% to $0.6450 after the company announced a new strategic collaboration with Celest Therapeutics for the clinical development of SENTI-301A in China. Tharimmune shares rose 76.8% to $0.2790 after disclosing an exclusive worldwide licensing agreement with Avior Bio to develop, market, and commercialize a clinical-stage asset, AV104. Lastly, TransMedics Group shares rose 39.7% to $56.16 following positive company reports.

TNON_OUT_13 [2025-03-27 09:45:01 -0400] 1108 Bytes | 285 tokens | Cum: 2690 tkns (33.62% of 8k)
==========================================================================

This is our list of SEC filings.
If empty, the search returned no recent filings.

S1 - 2025-03-26 10-K Item 7. MGT DISC & ANALYSIS OF FIN COND & RESULTS OF OPER

You should read the following discussion and analysis of our financial condition and results of operations together with our financial statements and the notes to those statements incl...

S2 - 2025-03-12 8-K Item 1.01. Entry into a Material Definitive Agrmt.

On March 11, 2025, Tenon Medical, Inc. (the Company) entered into a warrant exercise inducement offer letter agreement (the Inducement Letter) with a certain holder (the Holder) of outstanding Common Stock purchase warrants...

S3 - 2025-03-12 8-K Item 1.01. Entry into a Material Definitive Agrmt.

On March 11, 2025, Tenon Medical, Inc. (the Company) entered into a warrant exercise inducement offer letter agreement (the Inducement Letter) with a certain holder (the Holder) of outstanding Common Stock purchase warrants...

Request filing by its reference number. (Ex., "S1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.

TNON_IN_14 [2025-03-27 09:45:01 -0400] 2 Bytes | 2 tokens | Cum: 2692 tkns (33.65% of 8k)
==========================================================================

S2

TNON_OUT_15 [2025-03-27 09:45:08 -0400] 1098 Bytes | 293 tokens | Cum: 2985 tkns (37.31% of 8k)
==========================================================================

Showing S2 (chunk 1 of 5): S2:
Item 1.01. Entry into a Material Definitive Agreement.

On March 11, 2025, Tenon Medical, Inc. (the Company) entered into a warrant exercise inducement offer letter agreement (the Inducement Letter) with a certain holder (the Holder) of outstanding Common Stock purchase warrants exercisable for up to an aggregate of 2,445,700 shares (the Existing Warrants) of the Companys common stock, par value $0.001 per share (the Common Stock), which Existing Warrants were issued by the Company on September 16, 2024, and were originally exercisable at an exercise price of $4.28 per share.

Pursuant to the Inducement Letter, the Holder agreed to exercise the Existing Warrants for cash at a reduced exercise price of $1.25 per share in consideration for the Companys agreement to issue (i) new unregistered five-year warrants (the Series C-1 Warrants) to purchase up to an aggregate of 2,445,700 share

--> You can ask for 1) More of this item with: MOR, 2) the NEXt section with: NEX, or 3) a different item by it's handle (ex. C3, S2) (only 3 chars don't summarize yet)

TNON_IN_16 [2025-03-27 09:45:08 -0400] 381 Bytes | 95 tokens | Cum: 3080 tkns (38.50% of 8k)
==========================================================================

On March 11, 2025, Tenon Medical, Inc. entered into an agreement with a holder of outstanding Common Stock purchase warrants for up to 2,445,700 shares. The originally exercisable price was $4.28 per share, but it has been reduced to $1.25 per share. In return, the company has agreed to issue new unregistered five-year warrants to purchase up to an aggregate of 2,445,700 shares.

TNON_OUT_17 [2025-03-27 09:45:22 -0400] 4196 Bytes | 1201 tokens | Cum: 4281 tkns (53.51% of 8k)
==========================================================================

This is our set of metrics.
Please analyze the numbers.

+-------------------+----------------------+---------------------+-----------------------+------------------------+-------------------------+
| Volume: 0 | SMA50: 61.65% | Market Cap: 7.59M | Option/Short: No / No | Sales past 5Y: 238.26% | Sales Surprise: -11.21% |
+-------------------+----------------------+---------------------+-----------------------+------------------------+-------------------------+
| Avg Volume: 6.40M | SMA200: -26.46% | Shs Outstand: 3.14M | Short Float: 16.51% | Employees: 21 | EPS Surprise: 379.31% |
+-------------------+----------------------+---------------------+-----------------------+------------------------+-------------------------+
| Rel Volume: 0.00 | Perf Week: 105.08% | Shs Float: 3.14M | Short Ratio: 0.08 | Debt/Eq: 0.07 | P/E: - |
+-------------------+----------------------+---------------------+-----------------------+------------------------+-------------------------+
| RSI (14): 60.12 | Perf Month: 84.59% | Inst Own: 2.76% | Short Interest: 0.52M | Sales Y/Y TTM: 11.92% | Earnings: Mar 20 AMC |
+-------------------+----------------------+---------------------+-----------------------+------------------------+-------------------------+
| ATR (14): 0.55 | Perf Quarter: 31.52% | Insider Own: 0.00% | Beta: 1.19 | ROE: -405.19% | |
+-------------------+----------------------+---------------------+-----------------------+------------------------+-------------------------+
| SMA20: 74.08% | Index: - | Insider Trans: - | Sales Q/Q: -4.70% | ROI: -223.71% | |
+-------------------+----------------------+---------------------+-----------------------+------------------------+-------------------------+

The next section covers any insider trading.
If this section may be blank due to no recent filings.

[Company Financial Summary]
[Company Details]
Name: N/A
Market Cap: N/A
Shares Outstanding: N/A
Sector: N/A

[Financial Statements - Latest Quarter]
Total Assets: N/A
Total Liabilities: N/A
Total Equity: N/A
Revenue (Quarter): {'value': 887000, 'unit': 'USD', 'label': 'Revenues', 'order': 100}
Net Income: {'value': -3184000.0, 'unit': 'USD', 'label': 'Net Income/Loss', 'order': 3200}
Earnings Per Share (EPS): N/A

[Price Metrics - Last 30 Days]
Latest Close: 3.0906
Average Volume: 17162462.96
30-Day High: 3.75
30-Day Low: 0.9781

[Detailed Financials: Q3 2024]
- Total Assets: $13,039,000.0
- Total Liabilities: $4,848,000.0
- Total Equity: $8,191,000.0
- Current Assets: $11,188,000.0
- Current Liabilities: $3,178,000.0

[Income Statement: Q3 2024]
- Revenue: $887,000.00
- Net Income: N/A
- Gross Profit: N/A
- Operating Income: N/A
- Earnings Per Share (EPS): -3.63

[Cash Flow Statement: Q3 2024]
- Net Cash Flow: $7,194,000.0

[Detailed Financials: Q2 2024]
- Total Assets: $6,006,000.0
- Total Liabilities: $5,174,000.0
- Total Equity: $832,000
- Current Assets: $4,087,000.0
- Current Liabilities: $3,403,000.0

[Income Statement: Q2 2024]
- Revenue: $901,000.00
- Net Income: N/A
- Gross Profit: N/A
- Operating Income: N/A
- Earnings Per Share (EPS): -1.02

[Cash Flow Statement: Q2 2024]
- Net Cash Flow: $-2,420,000.0
==== END OF FINANCIAL REPORT ====

You are now requested to make a summary analysis.
Save explaining why you didn't have enough information for the final survey.

Now, complete this report with the following:

1) Brief Summary: explain your findings in succinct wording.
2) MARKET_SCORE: If you calculate a 92% likelihood of an upward moves, say: MARKET_SCORE[92]
3) PRICE_TARGET: If you think the high today will be 50% higher, add to the price.
Eg., If the current price is $5.00, add 50%. Thus, PRICE_TARGET[$7.50] -- It should be at or above the current price.
4) Provide a thought-provoking take, 6-10 words, to use for the headline of this news story.
Like this: AI_RPT_HEADLINE: [6-12 words headline for news story, distilled from summary]

1) Brief Summary, 2) MARKET_SCORE, 3) PRICE_TARGET, and 4) AI_RPT_HEADLINE

TNON_IN_18 [2025-03-27 09:45:22 -0400] 1166 Bytes | 288 tokens | Cum: 4569 tkns (57.11% of 8k)
==========================================================================

1) Brief Summary:

The company under review has shown a significant sales growth over the past 5 years (238.26%), and despite a recent sales surprise drop of -11.21%, it's showing strong signs of recovery. The stock's performance over the past week and month are impressive, with increases of 105.08% and 84.59% respectively. The average trading volume is also high at 6.4M. However, there are some red flags as the company's short float is quite high at 16.51% and the company's Return on Equity (ROE) is at a negative -405.19%. The company's recent earnings per share (EPS) surprise is a positive 379.31%, but the price-to-earnings (P/E) ratio is not available, indicating the company might not be profitable.

2) MARKET_SCORE[68]

Based on the company's past performance and current financial situation, the likelihood of an upward move in the market is assessed to be 68%.

3) PRICE_TARGET[$4.65]

Considering the company's recent performance and potential for growth, the price target is set at $4.65, which is 50% higher than the last close price of $3.09.

4) AI_RPT_HEADLINE:

"Sales Surge Amid Concerns: Is This High-Flying Stock Set For Further Growth?"

TNON_OUT_19 [2025-03-27 09:45:26 -0400] 676 Bytes | 167 tokens | Cum: 4736 tkns (59.20% of 8k)
==========================================================================

Finally, if more data could have improved your confidence which would you have chosen? **Choose one option:**
-> X0 <- Nothing more would have helped my analysis
-> X1 <- More stock-specific news
-> X2 <- More SEC filings (10-K, 10-Q, 8-K) Financials, risk disclosures, and business changes
-> X3 <- More SEC Insider Trading (Form 3, 4, 5) Direct buys/sells from executives and institutions
-> X4 <- Broader sector & market news
-> X5 <- Your past analysis on similar companies (specify metrics)
-> X6 <- More financial metrics
-> X7 <- Your past analysis on this exact company
-> X8 <- Something altogether different (explain...)

TNON_IN_20 [2025-03-27 09:45:26 -0400] 94 Bytes | 28 tokens | Cum: 4764 tkns (59.55% of 8k)
==========================================================================

-> X2 <- More SEC filings (10-K, 10-Q, 8-K) Financials, risk disclosures, and business changes

TNON_IN_21 [2025-03-27 09:45:26 -0400] 126 Bytes | 29 tokens | Cum: 4793 tkns (59.91% of 8k)
==========================================================================

====================================
[2025-03-27 06:45:26] # Analysis Completed
Elapsed Time: 46.13 seconds




Scroll to Top